NCT05827432Withdrawn
FCI Effectiveness in NAFLD Stratification
Field-Cycling Imaging Effectiveness in Non-alcoholic Fatty Liver Disease Stratification
Source: ClinicalTrials.gov · Last updated 1 Apr 2026
Reason given: Funding period ended.
Brief summary (registry, in English)
The goal of this pilot study is exploring whether field-cycling imaging may be able to detect characteristics of liver disease in patients with different degree of non-alcoholic fatty liver disease (NAFLD) that could be important in reflecting disease progression.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 10 Mar 2023
- Start date
- Mar 2026
- Primary completion date
- Mar 2026
- Lead sponsor
- NHS Grampian
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05827432
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- MRI-incompatible conditions, as detected in the MRI safety screening sheet
Age
- Participants under 18 years old
Other
- Participants who are unable to communicate in English
- Participants who are unable to give fully informed consent
- Women who are pregnant
- Restrictions to mobility that would prevent the correct positioning in the scanner
- Participants who suffer from claustrophobia
Who the study is looking for
- Participants with a diagnosis of NAFLD
- Participants must be aged 18 and above
- Participants who meet the safety criteria for undergoing an MRI scan
- Participants who are able to fit inside the scanner
- Participants must be able to give fully informed consent
- Participants must be mobile enough to be positioned onto the FCI scanner couch
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aberdeen Royal Infirmary | Aberdeen | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.